The FDA granted de novo approval to Neuromod Devices' Lenire, a bimodal neuromodulation device that is the first of its kind to be approved to treat tinnitus, the company announced. The device ...

FDA approval for the groundbreaking tinnitus treatment device, Lenire, was granted in March 2023 based on the success of the device's large-scale controlled clinical trial, TENT-A3. [1] TENT-A3 ...

The FDA-approved Lenire device that provides bimodal stimulation with a controller, tongue tip stimulator and wireless headphones. An FDA-approved device for treating tinnitus is showing strong ...

"So this is called the Lenire Tinnitus device. It's a bimodal neuromodulation tool. It's fancy for two pieces. So, piece one is using these headphones. This is the ear stimulation, and the second ...

Lenire is a bimodal neuromodulation device which has been shown to provide relief from tinnitus that can sustain for at least 12-months after treatment in large-scale clinical trials. [2],[3 ...